Pronóstico del mercado de sistemas de administración de fármacos transdérmicos de América del Sur y Central hasta 2030 – Análisis regional – por tipo (parches transdérmicos, gel transdérmico, aerosoles transdérmicos y otros), aplicación (enfermedades cardiovasculares, trastornos del sistema nervioso central, manejo del dolor, aplicaciones hormonales y otros Aplicaciones) y Canal de Distribución (Farmacias Hospitalarias, Farmacias Minoristas, Farmacias en Línea y Otros)
Avances en tecnología inteligente Los parches y los parches impresos en 3D impulsan el mercado de sistemas de administración transdérmica de medicamentos en América del Sur y Central
Una ruta de administración transdérmica de medicamentos es novedosa y uno de los medios confiables de administración sostenida de medicamentos. Con una importante investigación en este campo y el creciente interés de los investigadores en esta forma de administración de fármacos, es probable que en el futuro llegue al mercado un gran número de parches transdérmicos. Los parches transdérmicos se utilizan para administrar medicamentos como nicotina, fentanilo, nitroglicerina y clonidina para tratar diversas afecciones médicas. Recientemente, se han explorado estos parches para administrar productos biológicos en diversas aplicaciones. Los parches inteligentes están equipados con sensores y otras tecnologías para monitorear las condiciones del paciente y ajustar la administración de medicamentos en consecuencia. En enero de 2023, un científico principal de la Universidad de Swansea desarrolló un nuevo parche inteligente para detectar biomarcadores proinflamatorios de enfermedades neurodegenerativas como el Parkinson y el Alzheimer utilizando la tecnología de microagujas. Estos parches inteligentes comprenden numerosas microagujas diseñadas para penetrar la barrera cutánea de forma mínimamente invasiva, seguido de un seguimiento de los biomarcadores de importancia clínica. Pueden autoadministrarse para diagnóstico en el lugar de atención en consultorios generales o en casa. Esta investigación innovadora puede potencialmente cambiar el panorama de la detección temprana de enfermedades neurodegenerativas.
Según un artículo titulado \"Productos impresos en 3D para aplicaciones tópicas en la piel: desde apósitos personalizados hasta la administración de medicamentos\", publicado en la Biblioteca Nacional de Medicina en noviembre de 2021, se pueden usar parches impresos en 3D personalizados que se ajustan a la superficie de la piel. utilizado para la administración de acetil-hexapéptido 3 (AHP-3). En este estudio, se utilizaron dos monómeros líquidos, diacrilato de polietilenglicol (PEGDA) y vinilpirrolidona (VP), en diferentes proporciones para mejorar la resistencia mecánica, la tasa de polimerización y la tasa de hinchamiento del polímero final. La carga óptima del fármaco en la resina indicó que el AHP-3 permaneció estable durante todo el proceso de fabricación y no tuvo ningún efecto sobre las propiedades físicas del polímero final. Utilizando un modelo facial escaneado en 3D, se diseñó un parche personalizado en un software de diseño asistido por computadora y se fabricó en resina optimizada utilizando una impresora 3D de procesamiento de luz digital. La caracterización in vitro de los parches transdérmicos preparados ha demostrado su capacidad para penetrar la piel de cadáveres humanos y permanecer intactos tras la compresión. \"Productos impresos en 3D para aplicaciones tópicas en la piel: desde apósitos personalizados hasta la administración de medicamentos\" es el primer estudio que demuestra parches personalizados fabricados con fotopolímeros y ha introducido un enfoque novedoso para mejorar la administración transdérmica de medicamentos para el control eficaz de las arrugas.
Por lo tanto, es probable que la adopción de la tecnología de impresión 3D y los parches inteligentes ofrezca oportunidades al mercado de sistemas de administración transdérmica de medicamentos en los próximos años.
Resumen del mercado de sistemas de administración transdérmica de medicamentos en América del Sur y Central
El mercado de sistemas de administración transdérmica de medicamentos en América del Sur y Central incluye un análisis a nivel de país de Brasil, Argentina y el resto de América del Sur y Central. Se espera que Brasil tenga una participación de mercado significativa en esta región. Además, se prevé que crecerá a la tasa de crecimiento más alta. El crecimiento regional se atribuye a la creciente investigación, el aumento de los modelos de enfermedades y la prevalencia de la diabetes y las enfermedades cardiovasculares. Además, el desarrollo de tecnologías novedosas e innovadoras para el tratamiento médico brinda oportunidades lucrativas para que crezca el mercado de sistemas de administración transdérmica de medicamentos. Se espera que la creciente prevalencia de enfermedades cardiovasculares y diabetes en Brasil genere el desarrollo de nuevos productos durante los años previstos. Según la Federación Internacional de Diabetes, en 2021, la prevalencia comparativa de diabetes ajustada por edad en Brasil fue del 8,8% y se espera que aumente al 10,2% en 2030 y al 10,9% en 2045. La diabetes es una de las enfermedades epidémicas más agudas responsables de varias enfermedades coronarias. Esta creciente prevalencia de diabetes se ha traducido en un crecimiento del 60% en el índice de riesgo relacionado con enfermedades cardiovasculares asociadas con la diabetes. Por lo tanto, la alta prevalencia de enfermedades cardiovasculares y diabetes probablemente aumentará la demanda de sistemas de administración transdérmica de medicamentos, impulsando así el crecimiento del mercado.
Organizaciones públicas y privadas de Brasil concentran actividades estratégicas para desarrollar el negocio de los sistemas de administración transdérmica de medicamentos. Según un informe titulado \"Herramienta web de toma de decisiones para dejar de fumar (Pare de fumar conosco) entre pacientes con enfermedades crónicas en Brasil\", publicado por la Biblioteca Nacional de Medicina en enero de 2020, la herramienta web para dejar de fumar significativamente mayor interés en la farmacoterapia y el asesoramiento conductual. Según un informe titulado \"La Comisión Nacional para la Implementación del CMCT en Brasil (Conicq)\", publicado en octubre de 2022, el Ministerio de Salud -con el apoyo de la Fundación Oswaldo Cruz, el INCA y otras instituciones- está desarrollando un protocolo para prevenir , diagnosticar y tratar los riesgos laborales de los cultivadores de tabaco y sus familias. Asimismo, las organizaciones públicas y privadas del país están enfocadas en actividades estratégicas para desarrollar el negocio de los sistemas de administración transdérmica de medicamentos. Por ejemplo, el Ministerio de Salud de Brasil firmó un acuerdo con Rusan Group, con sede en India, para el programa para dejar de fumar. Según el acuerdo, el fármaco 2baconil de Rusan se utilizará en la agenda del gobierno brasileño para dejar de fumar en el país.
Por lo tanto, Brasil posee un gran potencial para desarrollar tecnología novedosa e innovadora y se espera que sea testigo de un crecimiento prometedor en el mercado de sistemas de administración transdérmica de medicamentos durante 2022-2030.
Ingresos del mercado de sistemas de administración de medicamentos transdérmicos de América del Sur y Central y pronóstico para 2030 (millones de dólares estadounidenses)
Segmentación del mercado de sistemas de administración de medicamentos transdérmicos de América del Sur y Central
El mercado de sistemas de administración de medicamentos transdérmicos de América del Sur y Central está segmentado por tipo, aplicación, canal de distribución y país.
Según el tipo, el mercado de sistemas de administración transdérmica de medicamentos de América del Sur y Central se segmenta en parches transdérmicos, gel transdérmico, aerosoles transdérmicos y otros. El segmento de gel transdérmico tuvo la mayor participación en el mercado de sistemas de administración transdérmica de medicamentos de América del Sur y Central en 2022. Los parches transdérmicos se subdividen aún más en parches de medicamento en adhesivo, parches de matriz, parches de membrana de reservorio y parches de vapor.
En términos de aplicación, el mercado de sistemas de administración transdérmica de medicamentos de América del Sur y Central se clasifica en enfermedades cardiovasculares, trastornos del sistema nervioso central, manejo del dolor, aplicaciones hormonales y otras aplicaciones. El segmento de manejo del dolor ocupó la mayor participación del mercado de sistemas de administración transdérmica de medicamentos de América del Sur y Central en 2022. El manejo del dolor se subsegmenta además en opioides y no opioides. Las aplicaciones hormonales se subdividen aún más en terapia transdérmica de estrógeno y progesterona y reemplazo de testosterona.
Por canal de distribución, el mercado de sistemas de administración transdérmica de medicamentos de América del Sur y Central está segmentado en farmacias hospitalarias, farmacias minoristas, farmacias en línea y otras. El segmento de farmacias hospitalarias tuvo la mayor participación del mercado de sistemas de administración transdérmica de medicamentos de América del Sur y Central en 2022.
Según el país, el mercado de sistemas de administración transdérmica de medicamentos de América del Sur y Central está segmentado en Brasil, Argentina y el resto de América del Sur y Central. Brasil dominó el mercado de sistemas de administración transdérmica de medicamentos de América del Sur y Central en 2022.
Boehringer Ingelheim International GmbH, GSK Plc, Hisamitsu Pharmaceutical Co Inc, Johnson & Johnson, Novartis AG y Viatris Inc son algunas de las empresas líderes que operan en el Mercado de sistemas de administración transdérmica de medicamentos en América del Sur y Central.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Transdermal Drug Delivery System Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic Diseases
4.1.2 Growing Demand for Noninvasive Drug Delivery Devices
4.1.3 High Demand for Self-Administration of Drugs
4.2 Market Restraints
4.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
4.3 Market Opportunities
4.3.1 Advancements in Smart Patches and 3D-Printed Patches
4.4 Future Trends
4.4.1 Strategic Initiatives by Manufacturers
4.5 Impact Analysis
5. Transdermal Drug Delivery System Market - South & Central America Market Analysis
5.1 South & Central America Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 - 2030
6. South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Type
6.1 Overview
6.2 South & Central America Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Transdermal Patches
6.3.1 Overview
6.3.2 Transdermal Patches: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 Drug-in-Adhesive Patches
6.3.2.1.1 Overview
6.3.2.1.2 Drug-in-Adhesive Patches: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.2 Matrix Patches
6.3.2.2.1 Overview
6.3.2.2.2 Matrix Patches: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.3 Reservoir Membrane Patches
6.3.2.3.1 Overview
6.3.2.3.2 Reservoir Membrane Patches: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.4 Vapor Patches
6.3.2.4.1 Overview
6.3.2.4.2 Vapor Patches: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Transdermal Gels
6.4.1 Overview
6.4.2 Transdermal Gels: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Transdermal Sprays
6.5.1 Overview
6.5.2 Transdermal Sprays: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Others
6.6.1 Overview
6.6.2 Others: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 South & Central America Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cardiovascular Diseases
7.3.1 Overview
7.3.2 Cardiovascular Diseases: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Central Nervous System Disorders
7.4.1 Overview
7.4.2 Central Nervous System Disorders: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Pain Management
7.5.1 Overview
7.5.2 Pain Management: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.5.2.1 Opioid
7.5.2.1.1 Overview
7.5.2.1.2 Opioid: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.5.2.2 Non-Opioid
7.5.2.2.1 Overview
7.5.2.2.2 Non-Opioid: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hormonal Applications
7.6.1 Overview
7.6.2 Hormonal Applications: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.6.2.1 Transdermal Estrogen & Progesterone Therapy
7.6.2.1.1 Overview
7.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.6.2.2 Testosterone Replacement
7.6.2.2.1 Overview
7.6.2.2.2 Testosterone Replacement: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Other Application
7.7.1 Overview
7.7.2 Other Application: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Distribution Channel
8.1 Overview
8.2 South & Central America Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Retail Pharmacies
8.4.1 Overview
8.4.2 Retail Pharmacies: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Online Pharmacies
8.5.1 Overview
8.5.2 Online Pharmacies: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - Country Analysis
9.1 South & Central America Transdermal Drug Delivery System Market
9.1.1 South & Central America Transdermal Drug Delivery System Market Share by Country - 2022 & 2030, (%)
9.1.1.1 Brazil: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.1.1 Overview
9.1.1.2 Brazil: South & Central America Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
9.1.1.2.1 Brazil: South & Central America Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.2.1.1 Brazil: South & Central America Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.2.2 Brazil: South & Central America Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.2.2.1 Brazil: South & Central America Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.2.2.2 Brazil: South & Central America Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.2.3 Brazil: South & Central America Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.3 Argentina: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.1 Overview
9.1.1.4 Argentina: South & Central America Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
9.1.1.4.1 Argentina: South & Central America Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.4.1.1 Argentina: South & Central America Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.4.2 Argentina: South & Central America Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.4.2.1 Argentina: South & Central America Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.4.2.2 Argentina: South & Central America Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.4.3 Argentina: South & Central America Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.5 Rest of South & Central America: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.5.1 Overview
9.1.1.6 Rest of South & Central America: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.6.1 Rest of South & Central America: South & Central America Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.6.1.1 Rest of South & Central America: South & Central America Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.6.2 Rest of South & Central America: South & Central America Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.6.2.1 Rest of South & Central America: South & Central America Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.6.2.2 Rest of South & Central America: South & Central America Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.6.3 Rest of South & Central America: South & Central America Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
10. Transdermal Drug Delivery System Market Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Transdermal Drug Delivery System Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Novartis AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Johnson & Johnson
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 GSK Plc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Viatris Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Boehringer Ingelheim International GmbH
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Hisamitsu Pharmaceutical Co Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
?
List of Tables
Table 1. South & Central America Transdermal Drug Delivery System Market Segmentation
Table 2. Brazil: South & Central America Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 3. Brazil: South & Central America Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 4. Brazil: South & Central America Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. Brazil: South & Central America Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 6. Brazil: South & Central America Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 7. Brazil: South & Central America Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 8. Argentina: South & Central America Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 9. Argentina: South & Central America Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 10. Argentina: South & Central America Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 11. Argentina: South & Central America Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 12. Argentina: South & Central America Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 13. Argentina: South & Central America Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of South & Central America: South & Central America Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of South & Central America: South & Central America Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of South & Central America: South & Central America Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of South & Central America: South & Central America Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of South & Central America: South & Central America Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 19. Rest of South & Central America: South & Central America Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 20. Recent Inorganic Growth Strategies in the Transdermal Drug Delivery System Market
Table 21. Recent Organic Growth Strategies in the Transdermal Drug Delivery System Market
Table 22. Glossary of Terms, South & Central America Transdermal Drug Delivery System Market
?
List of Figures
Figure 1. South & Central America Transdermal Drug Delivery System Market Segmentation, By Country
Figure 2. South & Central America Transdermal Drug Delivery System Market: Key Industry Dynamics
Figure 3. South & Central America Transdermal Drug Delivery System Market: Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Transdermal Drug Delivery System Market Revenue (US$ Mn), 2020 - 2030
Figure 5. South & Central America Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
Figure 6. Transdermal Patches: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Drug-in-Adhesive Patches: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Matrix Patches: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Reservoir Membrane Patches: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vapor Patches: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Transdermal Gels: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Transdermal Sprays: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. South & Central America Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
Figure 15. Cardiovascular Diseases: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Central Nervous System Disorders: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Pain Management: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Opioid: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Non-Opioid: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Hormonal Applications: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Transdermal Estrogen & Progesterone Therapy: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Testosterone Replacement: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Other Application: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. South & Central America Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 25. Hospital Pharmacies: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Retail Pharmacies: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Online Pharmacies: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. South & Central America Transdermal Drug Delivery System Market, By Key Country - Revenue (2022) (US$ Million)
Figure 30. South & Central America Transdermal Drug Delivery System Market Share by Country - 2022 & 2030, (%)
Figure 31. Brazil: South & Central America Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 32. Argentina: South & Central America Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 33. Rest of South & Central America: South & Central America Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Growth Strategies in the Transdermal Drug Delivery System Market
1. Boehringer Ingelheim International GmbH
2. GSK Plc
3. Hisamitsu Pharmaceutical Co Inc
4. Johnson & Johnson
5. Novartis AG
6. Viatris Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America Transdermal Drug Delivery System Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America Transdermal Drug Delivery System Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.